Online ISSN: 1949-2553

Cancer research treatment sets target on bacterial toxins

December 7, 2017
Targeting cancer cells while sparing healthy ones is a perennial challenge in oncology. But now, with the combination of targeting antibodies and a powerful bacterial toxin, researchers may have discovered a new method that can even kill drug-resistant cancer cells. In Dr. Ira Pastan’s Laboratory of Molecular Biology at the Center for Cancer Research at the National Cancer Institute in Bethesda, MD, researchers are using genetic engineering to target cancer cells. Dr. Pastan is widely known for his work in cellular biology, and sat down for a video with him to talk about his research on using bacterial toxins to… continue reading »